Antigenic cancer persister cells survive direct T cell attack

Area of Science:

• Immunology
• Cancer Biology
• Cellular Stress Response

Background:

• Drug-tolerant persister cancer cells are known to survive chemotherapy.
• The role of persister states in immune evasion remains largely unexplored.

Purpose of the Study:

• To investigate the existence and mechanisms of a persister cell state that survives cytotoxic T lymphocyte (CTL) attack.
• To determine if this persister state contributes to immune evasion and immunotherapy resistance.

Main Methods:

• Exposure of cancer cells to direct cytotoxic T lymphocyte (CTL) attack.
• Analysis of cellular responses, including apoptosis pathways and genetic/epigenetic changes.
• Examination of persister cell features in tumors from immunotherapy-treated patients and ex vivo stressed melanoma tissue.

Main Results:

• A persister cell state was identified that survives prolonged CTL attack.
• Persister cells paradoxically utilize apoptotic caspase activity to avoid inflammatory death.
• These cells acquire mutations and epigenetic alterations, leading to CTL resistance.
• Persister cell features are enriched in tumors that responded to immunotherapy and in ex vivo immune-stressed melanoma.

Conclusions:

• A novel persister cell state contributes to immune evasion by surviving CTL attack.
• This persister state represents a significant barrier to effective immune-mediated tumor clearance and immunotherapy.
• Understanding this phenomenon is crucial for developing strategies to overcome immunotherapy resistance.